Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey

被引:56
|
作者
Kehey, Amy S. [1 ]
Reid, M. Carrington [2 ]
Miller, David H. [3 ]
Fins, Joseph J. [4 ]
Lachs, Mark S. [2 ]
机构
[1] Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA USA
[2] Cornell Univ, Weill Med Coll, Div Geriatr & Gerontol, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Div Cardiol, New York, NY 10021 USA
[4] Cornell Univ, Weill Med Coll, Div Med Eth, New York, NY 10021 USA
关键词
QUALITY-OF-LIFE; CONGESTIVE-HEART-FAILURE; RECIPIENTS; COMPLICATIONS; DECISIONS; PACEMAKER; VIGNETTES; MANAGEMENT; FREQUENCY; DISEASE;
D O I
10.1016/j.ahj.2008.12.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Among older adults, implantable cardioverter-defibrillator (ICD) use is increasing. ICD shocks can occur at end of life (EOL) and cause substantial distress, warranting consideration of ICD deactivation discussions. This nationwide physician survey sought to (1) determine if physicians discuss ICD deactivation at the EOL, (2) identify predictors of those discussions, and (3) ascertain physicians' knowledge/attitudes about ICD use. Methods We surveyed 4,876 physicians stratified by specialty (cardiologists, electrophysiologists, general internists, and geriatricians). The mailed survey presented 5 vignettes leg, end-stage chronic obstructive pulmonary disease, advanced dementia) wherein ICD deactivation might be considered and 17 Likert-scaled items. Results Five hundred fifty-eight (12%) physicians returned surveys. Respondents were largely men (77%) and white (69%). Most physicians (56%-83%) said they would initiate deactivation discussions in all 5 vignettes, whereas significantly more (82%-94%) would discuss advance directives and do not resuscitate status. In logistic regression analyses, a history of prior deactivation discussions was an independent predictor of willingness to discuss deactivation (adjusted OR range, 2.8-8.8) in 4 of the 5 vignettes. General internists and geriatricians were less likely than electrophysiologists. to agree that ICD shocks are painful and to distinguish between the ICD's pacing and defibrillator functions. Finally, most physicians believed that informed consent for ICD implantation should include information about deactivation (77%) and endorsed the need for expert guidance in this area (58%). Conclusions Most physicians would discuss ICD deactivation at EOL. The strongest predictor of this was a history of prior discussions. Knowledge about ICDs varies by specialty, and most expressed a desire for more expert guidance about ICD management at EOL. (Am Heart J 2009; 157:702-8.)
引用
收藏
页码:702 / 708
页数:7
相关论文
共 50 条
  • [31] AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    EPSTEIN, AE
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1991, 102 (01): : 160 - 161
  • [32] The implantable cardioverter-defibrillator: An update
    Miller, Jared D.
    Yousuf, Omair
    Berger, Ronald D.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (07) : 606 - 611
  • [33] Implantable cardioverter-defibrillator utilization
    Camm, John
    EUROPACE, 2011, 13 (03): : 448 - 448
  • [34] Erosion of an Implantable Cardioverter-Defibrillator
    Elmouchi, Darryl
    Woelfel, Alan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (24) : E47 - E47
  • [35] Twiddling with an implantable cardioverter-defibrillator
    McCann, Conor J.
    Beelen, Roel
    Geelen, Peter
    ACTA CARDIOLOGICA, 2009, 64 (05) : 695 - 695
  • [36] Quality of life and acceptance of the extravascular implantable cardioverter-defibrillator
    Dankar, Razan
    Refaat, Marwan M.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2024, 35 (02) : 247 - 248
  • [37] The implantable cardioverter-defibrillator: patient care and quality of life
    Wellens, H. J.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (07): : 364 - 365
  • [38] The Capture Gap: Implantable Cardioverter-Defibrillator Quality of Life
    Hopgood, Daniel A.
    Czosek, Richard J.
    Bakas, Tamilyn
    Garritano, Nicole
    Gillespie, Gordon L.
    CLINICAL NURSING RESEARCH, 2020, 29 (02) : 97 - 107
  • [39] The implantable cardioverter-defibrillator: patient care and quality of life
    Hein J Wellens
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 364 - 365
  • [40] THE IMPACT OF THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR ON QUALITY-OF-LIFE
    MAY, CD
    SMITH, PR
    MURDOCK, CJ
    DAVIS, MJE
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1995, 18 (07): : 1411 - 1418